Laval, Canada

Laval Chan Kong

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laval Chan Kong. Retrieved from https://idiyas.com/inventor/laval-chan-kong-7cmxpjbd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Laval Chan Kong

Introduction

Laval Chan Kong is a notable inventor based in Laval, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-viral compounds. His work has the potential to impact the treatment of various viral infections.

Latest Patents

Laval Chan Kong holds 1 patent for his invention titled "Anti-viral compounds - Nucleotide analogues having the general formula (I) and pharmaceutically acceptable derivatives." This patent focuses on innovative nucleotide analogues that can be utilized in antiviral therapies.

Career Highlights

Throughout his career, Laval has demonstrated a commitment to advancing medical science through his research and inventions. His work has been recognized for its potential applications in treating viral diseases, showcasing his expertise in the pharmaceutical field.

Collaborations

Laval has collaborated with notable professionals in his field, including William Leslie Brown and Nghe Nguyen-Ba. These partnerships have contributed to the development and refinement of his innovative ideas.

Conclusion

Laval Chan Kong is a distinguished inventor whose work in anti-viral compounds exemplifies the importance of innovation in medicine. His contributions continue to pave the way for advancements in pharmaceutical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…